Cystic fibrosis and bronchiectasis: selection, timing, and outcome

Area of Science:

• Pulmonary Medicine
• Transplant Surgery
• Medical Prognostics

Background:

• Cystic Fibrosis (CF) accounts for a significant portion of lung transplant recipients, with respiratory failure due to bronchiectasis being a primary cause of mortality.
• A critical challenge in CF lung transplantation is identifying candidates within the optimal
• transplant window
• due to organ shortages.

Purpose of the Study:

• To evaluate the current criteria for selecting Cystic Fibrosis patients for lung transplantation.
• To explore the need for refined prognostic models and indicators for CF patients undergoing lung transplant.

Main Methods:

• Analysis of existing data on Cystic Fibrosis patient outcomes post-lung transplantation.
• Comparison of CF patient outcomes with other diagnoses, including living donor recipients.
• Review of international criteria for transplant candidate selection.

Main Results:

• Cystic Fibrosis patients represent approximately 40% of bilateral lung transplant recipients.
• Outcomes for CF patients are generally comparable to other diagnoses, with slightly lower rates for living donor recipients.
• CF patients may experience specific post-transplant complications, including infections, immunosuppression issues, and an increased risk of post-transplant lymphoproliferative disorder.

Conclusions:

• Current international criteria for lung transplant selection in Cystic Fibrosis patients may require refinement.
• Validated prognostic models are needed to improve the selection process for CF patients.
• Addressing unique post-transplant challenges in CF patients is essential for improving long-term survival and quality of life.